Bevra H. Hahn focuses on Internal medicine, Immunology, Lupus erythematosus, Endocrinology and Osteopenia. His work on Internal medicine deals in particular with Rheumatology, Rheumatism, Systemic lupus erythematosus, Psoriatic arthritis and Rheumatoid arthritis. His Immunology and Autoimmunity, Autoimmune disease, Antibody, Autoantibody and T cell investigations all form part of his Immunology research activities.
His Antibody research includes themes of Molecular biology and DNA. His research in Lupus erythematosus intersects with topics in Randomized controlled trial, Surgery, Systemic disease, Immunopathology and Lupus nephritis. His work in Immunopathology addresses issues such as Connective tissue disease, which are connected to fields such as Nephritis.
Bevra H. Hahn mainly focuses on Immunology, Internal medicine, Systemic lupus erythematosus, Antibody and Lupus erythematosus. All of his Immunology and Immune system, Autoantibody, Autoimmunity, Nephritis and Autoimmune disease investigations are sub-components of the entire Immunology study. The various areas that Bevra H. Hahn examines in his Internal medicine study include Gastroenterology and Endocrinology.
His study in the fields of Lipoprotein and Glucocorticoid under the domain of Endocrinology overlaps with other disciplines such as Osteopenia. Bevra H. Hahn has researched Antibody in several fields, including Molecular biology, Antigen, DNA and T cell. In his work, Systemic disease is strongly intertwined with Connective tissue disease, which is a subfield of Lupus erythematosus.
His primary areas of study are Internal medicine, Immunology, Systemic lupus erythematosus, Lupus erythematosus and Gastroenterology. His Internal medicine study frequently links to related topics such as Anti-nuclear antibody. Bevra H. Hahn has included themes like Genome-wide association study and Gene in his Immunology study.
His research investigates the connection with Systemic lupus erythematosus and areas like Autoantibody which intersect with concerns in Delirium and Acr criteria. His biological study spans a wide range of topics, including Dermatology, Prospective cohort study, Odds ratio and Severity of illness. His studies deal with areas such as microRNA and Pathogenesis as well as Autoimmunity.
Bevra H. Hahn spends much of his time researching Lupus erythematosus, Immunology, Internal medicine, Genome-wide association study and Autoimmune disease. His Lupus erythematosus research is multidisciplinary, incorporating elements of Odds ratio, Dermatology, Gastroenterology, Immunosuppression and Lupus nephritis. His study in Cytokine, Autoimmunity, Inflammation, Pathogenesis and Immune system falls within the category of Immunology.
As a member of one scientific family, Bevra H. Hahn mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Prospective cohort study. The concepts of his Genome-wide association study study are interwoven with issues in Regulation of gene expression, Allele and Genetic predisposition. His Autoimmune disease research includes elements of Lipid oxidation, Aryldialkylphosphatase, Case-control study, Type 1 diabetes and Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human polymorphism at microRNAs and microRNA target sites.
Liuqing Yang;Chunru Lin;Chunyu Jin;Joy C. Yang.
Frontiers in Genetics (2013)
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
Bevra H. Hahn;Maureen A. McMahon;Alan Wilkinson;W. Dean Wallace.
Arthritis Care and Research (2012)
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Michelle Petri;Mimi Y. Kim;Kenneth C. Kalunian;Jennifer Grossman.
The New England Journal of Medicine (2005)
Antibodies to DNA
Bevra Hannahs Hahn.
The New England Journal of Medicine (1998)
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial
Jill P. Buyon;Michelle A. Petri;Mimi Y. Kim;Kenneth C. Kalunian.
Annals of Internal Medicine (2005)
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks.
Arthritis & Rheumatism (2019)
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.
Ellen M. Ginzler;Ellen M. Ginzler;Herbert S. Diamond;Max Weiner;Michael Schlesinger.
Arthritis & Rheumatism (1982)
Proinflammatory high‐density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis
Maureen McMahon;Jennifer Grossman;John FitzGerald;Erika Dahlin-Lee.
Arthritis & Rheumatism (2006)
Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.
Theodore J. Hahn;Linda R. Halstead;Steven L. Teitelbaum;Bevra H. Hahn.
Journal of Clinical Investigation (1979)
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death
Steven Rosner;Ellen M. Ginzler;Ellen M. Ginzler;Herbert S. Diamond;Max Weiner.
Arthritis & Rheumatism (1982)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: